Clik here to view.
New Treatment Option Approved For Lennox-Gastaut Syndrome
The U.S. FDA has approved Topamax (topiramate) tablets and sprinkle capsules as an adjunctive (add-on) treatment for adults and children (age 2-16) suffering from seizures associated with...
View ArticleClik here to view.
Ortho-McNeil To Acquire U.S. Rights To AXERT
Ortho-McNeil Pharmaceutical, Inc. is to acquire the U.S. sales and marketing rights to AXERT (almotriptan malate) Tablets, pursuant to a licensing agreement with the drug’s innovator Almirall. AXERT...
View ArticleClik here to view.
New Treatment Option Approved For Lennox-Gastaut Syndrome
The U.S. FDA has approved Topamax (topiramate) tablets and sprinkle capsules as an adjunctive (add-on) treatment for adults and children (age 2-16) suffering from seizures associated with...
View ArticleClik here to view.
Ortho-McNeil To Acquire U.S. Rights To AXERT
Ortho-McNeil Pharmaceutical, Inc. is to acquire the U.S. sales and marketing rights to AXERT (almotriptan malate) Tablets, pursuant to a licensing agreement with the drug’s innovator Almirall. AXERT...
View Article
